The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of 36 months of androgen-deprivation therapy (ADT) on physical function and quality of life (QOL) in men with nonmetastatic prostate cancer.
Shabbir M.H. Alibhai
No relevant relationships to disclose
Henriette Breunis
No relevant relationships to disclose
Narhari Timilshina
No relevant relationships to disclose
George A. Tomlinson
No relevant relationships to disclose
Sarah Duff Canning
No relevant relationships to disclose
Neil Eric Fleshner
No relevant relationships to disclose
Murray Krahn
No relevant relationships to disclose
Ian Tannock
No relevant relationships to disclose
Padraig Richard Warde
No relevant relationships to disclose
Gary Naglie
No relevant relationships to disclose